Heim / Peptid-Wiki / Thymosin Alpha-1 (Tα1)
Immun

Thymosin Alpha-1 (Tα1)

Immunmodulator

Thymic peptide and potent immune system modulator. FDA-approved (Zadaxin) in 37 countries for hepatitis B, hepatitis C, and immunodeficiency. Activates dendritic cells, NK cells and Th1 response.

Aminosäuren28
Mol. Gewicht3108.5 Da
Halbwertszeitca. 2 Stunden
Verfügbarkeit 🔔 Auf Anfrage
Aminosäuresequenz Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

What Is Thymosin Alpha-1?

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino-acid peptide derived from prothymosin alpha in thymic tissue. It is approved in 37 countries (as Zadaxin, SciClone) for treatment of hepatitis B, hepatitis C, and immunodeficiency states. It is also under investigation for sepsis and cancer immunotherapy enhancement.

Schlüsselmechanismen

  • Dendritic cell activation — matures immature DCs and enhances antigen presentation
  • Th1 polarisation — shifts immune response toward cellular immunity via IL-12 and IFN-γ production
  • NK cell enhancement — increases natural killer cell cytotoxicity
  • TLR-9 signalling — activates innate immune recognition pathways
  • T-cell maturation — stimulates differentiation of T-cell precursors in thymus and periphery

Wichtige Referenzen

  1. Garaci E et al. “Thymosin alpha1 in the treatment of cancer.” Ann N Y Acad Sci, 2012;1270:26–31.
  2. Romani L et al. “Thymosin alpha 1 activates dendritic cell tryptophan catabolism.” J Clin Invest, 2004;114:1579–1588.
🔬

Peptid anfordern

Füllen Sie das Formular aus, und wir melden uns innerhalb von 24 Stunden bei Ihnen.